<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="H0D339C6752634B90AD635FA6C0E8D388" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>118 HR 1090 IH: Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2023</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2023-02-17</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">118th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 1090</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20230217">February 17, 2023</action-date><action-desc><sponsor name-id="L000582">Mr. Lieu</sponsor> (for himself, <cosponsor name-id="C001080">Ms. Chu</cosponsor>, and <cosponsor name-id="N000147">Ms. Norton</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To amend the Federal Food, Drug, and Cosmetic Act to enhance medical device communications and ensure device cleanliness.</official-title></form><legis-body id="HD70E3123E55C4301B94C6251A600C9C0" style="OLC"><section id="HAC7427C6C0FE4083BB8BEFF085C94769" section-type="section-one"><enum>1.</enum><header>Short title</header><text display-inline="no-display-inline">This Act may be cited as the <quote><short-title>Disclosure; and Encouragement of Verification, Innovation, Cleaning, and Efficiency Act of 2023</short-title></quote> or the <quote><short-title>DEVICE Act of 2023</short-title></quote>.</text></section><section id="H4D8B66BAC44F45069A9EAEE8FF202AF4"><enum>2.</enum><header>Reporting requirement for design and reprocessing instruction changes</header><subsection id="HC9132F191EF04209AE7C2E0F53389B8E"><enum>(a)</enum><header>Adulteration</header><text display-inline="yes-display-inline">Section 501 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351</external-xref>) is amended by inserting after paragraph (j) the following:</text><quoted-block display-inline="no-display-inline" id="H6436A39C97E04986888A6B3711BA5B09" style="OLC"><subsection id="HCBD1FC2A2F7742F588B821C02F4B41C7"><enum>(k)</enum><text display-inline="yes-display-inline">If it is a device with respect to which the manufacturer is in violation of the reporting requirement under section 510(r) (relating to design and reprocessing changes).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H2E2F2193FB0045DDADF41DBAAB088556"><enum>(b)</enum><header>Requirement</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>) is amended by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="HE4B47F1B30DC42B3A57D9CE1F6FD1287" style="OLC"><subsection id="H2A80BF84E095458CA01CB5FDC98297C4"><enum>(r)</enum><header>Reporting requirement for device design changes</header><text display-inline="yes-display-inline">Before making a change to the design of a device, or the reprocessing instructions of a device, that is marketed in interstate commerce, the manufacturer of the device shall give written notice of the change to the Secretary.</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section><section id="H0461E149FD094DD09833404B788BA2BD"><enum>3.</enum><header>Reporting requirement for certain communications to foreign health care providers</header><subsection id="HC1CD98DFF6C94C0397ABD5232897977F"><enum>(a)</enum><header>Adulteration</header><text display-inline="yes-display-inline">Section 501 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/351">21 U.S.C. 351</external-xref>), as amended by section 2 of this Act, is further amended by inserting after paragraph (k) the following:</text><quoted-block display-inline="no-display-inline" id="HFD00C7D59D3940978FACBB5014D08357" style="OLC"><subsection id="H72CC58C48B5740638EDFEFFA9E6E8DA7"><enum>(l)</enum><text display-inline="yes-display-inline">If it is a device with respect to which the manufacturer is in violation of the reporting requirement under section 510(s) (relating to communications to foreign health care providers).</text></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection><subsection id="H81829F405933429CBE1C3C6F9A25C39B"><enum>(b)</enum><header>Requirement</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), as amended by section 2 of this Act, is further amended by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="H06D88D518A2E491CA64B015B9D90516E" style="OLC"><subsection id="HC37236FFA1404C2986ECB516CE333F48"><enum>(s)</enum><header>Reporting requirement for certain communications to foreign health care providers</header><paragraph id="HF5D621E4460949CEB69729AE7CBF3822"><enum>(1)</enum><header>Requirement</header><text display-inline="yes-display-inline">The manufacturer of a device that is marketed in interstate commerce shall give written notice to the Secretary of any communication described in paragraph (2) not more than 5 calendar days after making such communication.</text></paragraph><paragraph id="H95EB5F88A6654DB6987DC64068641E39"><enum>(2)</enum><header>Communication described</header><text>A communication is described in this paragraph if the communication—</text><subparagraph id="H24EC84B54DC4473E939586CE0438A692"><enum>(A)</enum><text>is made by the manufacturer of the device or an affiliate of the manufacturer;</text></subparagraph><subparagraph id="HB797A4D4F735408A97243C0E272236D8"><enum>(B)</enum><text>relates to a change to the design of the device, a change to the recommended reprocessing protocols, if any, for the device, or a safety concern about the device; and</text></subparagraph><subparagraph id="HE347252C82B34748865D0A1303994C6B"><enum>(C)</enum><text>is widely disseminated (including on a voluntary basis) to health care providers in a foreign country.</text></subparagraph></paragraph><paragraph id="H76D7300BE20B4D468DEEE335F3E440AD"><enum>(3)</enum><header>Affiliate</header><text display-inline="yes-display-inline">In this subsection, the term <term>affiliate</term> means a business entity that has a relationship with a second business entity if, directly or indirectly—</text><subparagraph id="HC83152B2322041D4A4358926A1C374AF"><enum>(A)</enum><text>one business entity controls, or has the power to control, the other business entity; or</text></subparagraph><subparagraph id="HBA9A1B69A5504A2EB94DE21859370F24"><enum>(B)</enum><text>a third party controls, or has the power to control, both of the business entities.</text></subparagraph></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section><section id="HA1FF0AD2AC654DF0A3EADB32595355D5"><enum>4.</enum><header>Rapid assessment tests intended to ensure proper reprocessing</header><subsection id="HE4ABF59ACA8343EDB4DFC29A080AD80F" commented="no"><enum>(a)</enum><header>Inclusion in device definition</header><text display-inline="yes-display-inline">Section 201 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321</external-xref>) is amended—</text><paragraph id="HC60CE3CA122549A6AE11EE9C01F825CD" commented="no"><enum>(1)</enum><text>in paragraph (h)(1)—</text><subparagraph id="H02AF02CFB30D4F51B628863E46CEBDBF" commented="no"><enum>(A)</enum><text>in clause (B), by striking <quote>or</quote> at the end;</text></subparagraph><subparagraph id="H86872510DDD9462980A88B02FFA1BA81" commented="no"><enum>(B)</enum><text display-inline="yes-display-inline">in clause (C), by striking <quote>and</quote> at the end and inserting <quote>or</quote>; and</text></subparagraph><subparagraph id="H04A8C3FEFD564D91A2D9E70D0B78F4A2" commented="no"><enum>(C)</enum><text display-inline="yes-display-inline">by inserting after clause (C) the following:</text><quoted-block display-inline="no-display-inline" id="HB4F6B3FEE2AF4C95BCB99541771FB978" style="OLC"><subparagraph id="H1A813B7919C14F4E8A32F933340CC2A6" commented="no" indent="up2"><enum>(D)</enum><text display-inline="yes-display-inline">a rapid assessment test intended to ensure the proper reprocessing of a reusable device (as defined in paragraph (ss)), and</text></subparagraph><after-quoted-block>; and</after-quoted-block></quoted-block></subparagraph></paragraph><paragraph id="H65AAA1735B8945EAA564C922222FD3F3" commented="no"><enum>(2)</enum><text>by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="H932C41CE178B4BCDAF7C890DEBB97AF6" style="OLC"><subsection id="H7E73DBB3FCC04FB1998909E5EF2FE0D1" commented="no"><enum>(ss)</enum><text display-inline="yes-display-inline">The term <term>reusable device</term> means a device that—</text><paragraph id="H1449C98B3AEE40E08B7AB985CD146105" commented="no"><enum>(1)</enum><text>is intended to be used more than one time; and</text></paragraph><paragraph id="H24E8FBB592FA4F49BDBC375BB8AEFE20" commented="no"><enum>(2)</enum><text display-inline="yes-display-inline">must be sanitized (whether through cleaning, disinfection, or sterilization) to ensure that the device is safe and effective for such intended use.</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></paragraph></subsection><subsection id="H51C2735DABC04573BFB528CBE62DFF9C"><enum>(b)</enum><header>Instructions for use and validation data</header><text display-inline="yes-display-inline">Section 510 of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/360">21 U.S.C. 360</external-xref>), as amended by sections 2 and 3 of this Act, is further amended by adding at the end the following:</text><quoted-block display-inline="no-display-inline" id="HE132C49B6C914A9499E398ED0617ED12" style="OLC"><subsection id="H42C35FE4CED541E7B10DB4CD6AB951D3"><enum>(t)</enum><header>Instructions for use and validation data</header><paragraph id="H6E5202E3D2694EE68461EE22E172F555"><enum>(1)</enum><header>Initial list</header><text display-inline="yes-display-inline">Not later than 1 year after the date of enactment of this subsection, the Secretary shall by regulation develop and publish a list of types of rapid assessment tests described in section 201(h)(1)(D) for which reports under subsection (k) must include—</text><subparagraph id="HFDAD34CFC7504D1D8C3ECADA232FB54F"><enum>(A)</enum><text>instructions for use that have been validated in a manner specified by the Secretary; and</text></subparagraph><subparagraph id="HD89AE8183D154DDB8834D312728E5E7F"><enum>(B)</enum><text>validation data, of the types specified by the Secretary.</text></subparagraph></paragraph><paragraph id="HE35257D1C2E5474FAC3AC687AD85E5FD"><enum>(2)</enum><header>Updates</header><text display-inline="yes-display-inline">The Secretary shall by regulation periodically update the list required by paragraph (1).</text></paragraph><paragraph id="H9A469ACEB24A4004850ED048058D8DD6"><enum>(3)</enum><header>Enforcement</header><text>Beginning on the date of publication of the initial list under paragraph (1), the Secretary shall not accept any notification under subsection (k) for clearance of a type of rapid assessment test that is included on such list unless such notification includes instructions for use and validation data in accordance with paragraph (1).</text></paragraph></subsection><after-quoted-block>.</after-quoted-block></quoted-block></subsection></section></legis-body></bill> 

